Home - Australian Pharmacist

Why is my PPI not working?

AP Staff - March 12, 2000

CPD

References Gastro-oesophageal reflux in adults . In: Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. At: www.tg.org.au Daniels B, Schaffer A, Buckley NA, et al. The...

From the President: Caring for older Australians with compassion and expertise

Dr Fei Sim FPS BPharm (Hons) PhD FHEA GAICD FPS - May 5, 2000

Industry

At PSA we are proud to advocate for the critical role that pharmacists play in palliative care and aged care for medication supply and...

Metformin for wet (neovascular) age-related macular degeneration

Dr Esther Lau and Prof Lisa Nissen - June 12, 2000

CPD

References Khanna S, Shaw L, Hyman MJ, et al. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina...

Clinical governance and the role of the pharmacist

AP Staff - October 16, 2000

CPD

References National Australia Bank Limited NAB Health Insights Special Report Part 1: The Health Consumer. November 2022. NAB Behavioural and Industrial Economics. At: https://business.nab.com.au/nab-health-insights-2022-56900/ ...

James Chalmers and Peter Guthrey MPS - August 9, 2000

Industry

Pharmacy practice is rapidly evolving. Here’s how the drastically reimagined Professional Practice Standards can help the profession adapt.

Keeping it renal

Chloe Hava - July 12, 2000

People

Outside his usual kidney care, renal pharmacist Lindon Clark can be found hiking and climbing around Queensland.

1...279280281...284 Page 280 of 284

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Which RSV vaccines will pharmacists administer?

How popular will it be?

What is covered for pharmacists under the NIP?

What about protection for neonates?

Why did the government decide to take action against RSV?

What’s the expected impact?

Will older patients be able to receive the RSV vaccine under the NIP?

The injectables are coming

New formats needed

Improving medicine adherence

Breakthrough in injectable PrEP

Pharmacist focus on patient care

References

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time

What the health sector is saying

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Which RSV vaccines will pharmacists administer?

How popular will it be?

What is covered for pharmacists under the NIP?

What about protection for neonates?

Why did the government decide to take action against RSV?

What’s the expected impact?

Will older patients be able to receive the RSV vaccine under the NIP?

The injectables are coming

New formats needed

Improving medicine adherence

Breakthrough in injectable PrEP

Pharmacist focus on patient care

References

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time

What the health sector is saying

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Which RSV vaccines will pharmacists administer?

How popular will it be?

What is covered for pharmacists under the NIP?

What about protection for neonates?

Why did the government decide to take action against RSV?

What’s the expected impact?

Will older patients be able to receive the RSV vaccine under the NIP?

The injectables are coming

New formats needed

Improving medicine adherence

Breakthrough in injectable PrEP

Pharmacist focus on patient care

References

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time